Document:

Exhibit 10.2

Exhibit 10.2

This document constitutes part of a prospectus covering securities that have been registered under the Securities Act of 1993.

BlueLinx Holdings Inc.

2006 Long-Term Equity Incentive Plan

Restricted Stock Award Agreement

THIS RESTRICTED STOCK AWARD AGREEMENT (the “Agreement”) is made effective as of                     , 20_____ 

(the
“Effective Date”), by and between BlueLinx Holdings Inc., a Delaware corporation (the “Company”),
and                                          (“Participant”).

Recitals

A. The Company desires to provide the Participant an opportunity to acquire shares of its
common stock, par value $.01 per share (the “Shares”), to carry out the purposes of its 2006
Long-Term Equity Incentive Plan, as may be periodically amended (the “Plan”), a copy of which has
been made available to Participant and the terms of which are incorporated by reference herein and
shall be considered a part of this Agreement.

B. The Plan provides that each award is to be evidenced by an agreement, setting forth the
terms and conditions of such award.

ACCORDINGLY, in consideration of the promises and of the mutual covenants and agreements
contained herein, the Company and the Participant hereby agree as follows:

1. Restricted Stock Award. Subject to the terms and provisions of this Agreement and the Plan,
the Company hereby grants to Participant as of the date hereof a restricted stock award for
                                        
(_____) Shares (the “Award Shares”). For purposes of Section 16 under the
Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, the grant
date for the Award Shares shall be the effective date hereof; provided, however, all of
Participant’s right, title, and interest in and to the Award Shares shall be subject to Section 2
below.

2. Vesting of Award Shares.

(a) Vesting. Subject to Sections 2(b), (c) and (d) below, all of Participant’s
right, title, and interest in and to the Award Shares is and shall be contingent upon and
subject to the Participant remaining a member of the Board of Directors of the Company
during the period from the Effective Date through                     , 20_____ 

(the “Service Vesting
Period”). At the end of the Service Vesting Period, and provided that Participant is then a
member of the
Board of Directors of the Company, Participant shall be deemed to be fully vested
without restriction in all of the Award Shares.

 

 

 

(b) In the event Participant ceases to be a member of the Board of Directors of the
Company for any reason other than the death or Disability prior to the end of the Service
Vesting Period, Participant shall forfeit all right, title, and interest in and to the Award
Shares not vested as of such date of termination.

For the purposes to this Agreement, Disability shall have the same meaning as provided
in the Company’s long-term disability plan.

(c) In the event Participant ceases to be a member of the Board of Directors of the
Company as a result of death or Disability prior to the end of the Service Vesting Period,
Participant shall become immediately fully vested without restriction in all Award Shares
granted pursuant to this Agreement.

(d) In the event of a “Change in Control” of the Company as defined in the Plan,
Participant shall thereupon become immediately vested without restriction in all of the
Award Shares.

3. Issuance and Delivery of Certificates for Award Shares.

(a) As soon as practicable after the execution hereof, the Company shall issue in
Participant’s name, and retain in the custody of the Company pursuant to Section 3(b) below,
a certificate for the full number of the Award Shares. The Company shall place a stop
transfer order on its stock records with respect to the Award Shares, and the certificate
for the Award Shares shall contain the following legend:

“The securities evidenced by this certificate were issued
pursuant to a Restricted Stock Award Agreement between the
holder and the issuer dated
 _____, 20_____ 

(the “Agreement”),
and no sale, offer to sell, transfer, pledge, or other
hypothecation of these securities may be made so long as the
securities remain subject to the restrictions set forth in
the Agreement.”

(b) Participant acknowledges and agrees that the Company shall retain the custody of
the certificates for the Award Shares and that the certificates will not be delivered to
Participant except as provided in Section 3(c) below.

(c) As soon as reasonably practicable after the vesting of the Award Shares pursuant to
Section 2 above, the Company will deliver a certificate for the Award Shares, adjusted as
necessary for the actual number of Award Shares in which Participant has become vested,
without the restrictive legend set forth in Section 3(a). Delivery of the certificate under
this Section 3(c) shall be made at the principal office of the Company to the person or
persons entitled thereto during ordinary business hours of the Company not more than thirty
(30) days after the vesting of the Award Shares, or at such time and place and in such
manner as may be determined by the Company.

Hewitt Associates

 

2

 

4. Rights and Restrictions as a Shareholder. During the Participant’s continued service as a
member of the Board of Directors of the Company, and pending the vesting of the Award Shares under
Section 2 above, Participant shall have full voting rights, dividend rights, and other rights as a
shareholder with respect to the Award Shares, subject to the restrictions hereunder. Prior to
vesting of the Award Shares, Participant shall not (i) sell, offer to sell, transfer, pledge, or
hypothecate any record or beneficial interest in the Award Shares, other than to the Company as
provided in this Agreement, or (ii) grant any proxies or voting rights with respect to the Award
Shares. Upon the vesting of the Award Shares pursuant to Section 2 above, Participant (or the
person or persons then entitled to the Award Shares or any portion thereof pursuant to Section 2(c)
above) shall have full rights as a shareholder with respect to the number of Shares delivered with
respect to the Award Shares, including the right to transfer ownership of the Award Shares, subject
to the restrictions described in Sections 7 and 8 hereof.

5. Stock Dividends, Stock Splits, and Other Adjustments. During the time that the Award Shares
are subject to the vesting restrictions set forth in Section 2 above, in the event of any merger,
reorganization, consolidation, capitalization, stock dividend, stock split, or other change in
corporate structure affecting the Shares, such substitution or adjustment shall be made in the
number of Shares subject to this Award (“Adjusted Shares”) as may be determined to be appropriate
by the board of directors, in its sole discretion. As used herein, the term “Award Shares” includes
any related Adjusted Shares. The Company shall retain the custody of each certificate for the
Adjusted Shares pursuant to Section 3 above.

6. Withholding Taxes. Participant shall pay on a timely basis all withholding and payroll
taxes and/or excise taxes required by law with respect to the Award Shares (collectively,
“Withholding Taxes”). The delivery of any Award Shares (or portion thereof) to Participant under
this Agreement shall be subject to and conditioned upon Participant’s payment of all applicable
Withholding Taxes. The Company shall have the power and the right to deduct or withhold vested
Award Shares equal to the minimum statutory amount to satisfy federal, state, and local taxes,
domestic or foreign, required by law or regulation to be withheld with respect to any taxable event
arising as a result of this Plan.

7. Investment Representations. Unless a registration statement under the Securities Act of
1933, as amended (and applicable state securities laws), is in effect with respect to the Award
Shares on the date of issuance of the Award Shares, Participant, or his Designated Beneficiary,
agrees with, and represents to, the Company that Participant is acquiring the Award Shares for the
purpose of investment and not with a view to transfer, sell, or otherwise dispose of the Award
Shares. The Company may require an opinion of counsel satisfactory to it prior to the transfer of
any Award Shares to assure at all times that it will be in compliance with applicable federal and
state securities laws.

8. Legend on Shares if Registered. If a registration statement under the Securities Act of
1933, as amended, is in effect with respect to the Award Shares on the date of issuance of the
Award Shares and Participant is deemed an affiliate of the Company on the date of issuance, the
Company may place a stop transfer order on its stock records with respect to the Award Shares, and
the certificate(s) for the Award Shares may contain substantially the following legend:

“The securities evidenced by this certificate were issued to an
affiliate of the issuer, and the resale of such securities is subject to
the restrictions of
Rule 144 under the Securities Act of 1933, as amended, pertaining to
 shares held by affiliates.”

Hewitt Associates

 

3

 

9. Expenses. Nothing contained in this Agreement shall be construed to impose any liability on
the Company in favor of the Participant for any cost, loss, or expense the Participant may incur in
connection with, or arising out of any transaction under, this Agreement.

10. No Employment Agreement. Nothing in this Agreement shall be construed to constitute or be
evidence of an agreement or understanding, express or implied, on the part of the Company to employ
the Participant on any terms or for any specific period of time.

11. Nontransferability. The rights of the Participant under this Agreement shall not be
assigned, transferred, pledged, or otherwise hypothecated by the Participant other than by will or
the laws of descent and distribution.

12. Fractional Shares. No fraction of a share shall be deliverable pursuant to this Agreement,
but in the event any adjustment hereunder of the number of the Award Shares shall cause such number
to include a fraction of a share, such fraction shall be adjusted to the nearest smaller whole
number of shares.

13. Beneficiary Designation. The Participant may, from time to time, name any beneficiary or
beneficiaries (who may be named contingently or successively) to whom any benefit under this
Agreement is to be paid in case of his or her death before he or she receives any or all such
benefit. Each such designation shall revoke all prior designations by the Participant, shall be in
a writing form prescribed by the Company, and will be effective only when filed by the Participant
in writing with the Secretary of the Company during the Participant’s lifetime. In the absence of
any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the
Participant’s estate.

14. Complete Agreement, Amendment. This Agreement and the Plan, which by this reference is
hereby incorporated herein in its entirety, contain the entire agreement between the Company and
Participant with respect to the transactions contemplated hereby. Any modification of the terms of
this Agreement must be in writing and signed by each of the parties.

15. Other Legal Requirements. This Agreement and the rights of the Participant hereunder are
subject to all the terms and conditions of the Plan, as the same may be amended from time to time,
as well as to such rules and regulations as the Committee may adopt for administration of the Plan.
The Committee shall have the right to impose such restrictions on any shares acquired pursuant to
this Agreement, as it may deem advisable, including, without limitation, restrictions under federal
applicable securities laws, under the requirements of any stock exchange or market upon which such
shares are then listed and/or traded, and under any blue sky or state securities laws applicable to
such shares. In addition, this Agreement shall be subject to all applicable laws, rules, and
regulations, and to such approvals by any governmental agencies or national securities as may be
required.

16. Governing Law. Any issue related to the formation, execution, performance, and
interpretation of this Agreement shall be governed by the laws of the State of Delaware.

Hewitt Associates

 

4

 

17. Headings. The section and subsection headings used in this Agreement are for convenient
reference and are not a part of this Agreement.

	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	BlueLinx Holdings Inc.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Dated:                     , 20__	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	Accepted:

	 	 	 	 	 	Name:
	 	George R. Judd	 	 
	 

	 	 

	 	 	 	Title:
	 	Chief Executive Officer	 	 

Hewitt Associates

 

5exv10w31w1

Exhibit 10.31.1

DISCLOSURE SCHEDULE

     In connection with that certain Common Stock Purchase Agreement (the “Agreement”) dated as of
December 14, 2010, by and between Cardica, Inc., a Delaware corporation (the “Company”)
and Aspire Capital Fund LLC., an Illinois limited liability company (“Aspire Capital”),
the Company hereby delivers this Disclosure Schedule to the Company’s representations and
warranties given in Section 3 of the Agreement. The section numbers in this Disclosure Schedule
correspond to the section numbers in the Agreement; provided, however, that any information
disclosed herein under any section number shall be deemed to be disclosed and incorporated in any
other section of the Agreement where such disclosure would be appropriate and reasonably apparent
from the face of the disclosure. Disclosure of any information or document herein is not a
statement or admission that it is material or required to be disclosed herein. References to any
document do not purport to be complete and are qualified in their entirety by the document itself.

Schedule 3(a) — Subsidiaries

     None.

Schedule 3(c) — Capitalization

     (iii)

Options and Awards As of November 30, 2010

In 1997, the Company adopted the 1997 Equity Incentive Plan (the “1997 Plan”). The 1997 Plan
provides for the granting of options to purchase common stock and the issuance of shares of common
stock, subject to Company repurchase rights, to directors, employees and consultants. Certain
options are immediately exercisable, at the discretion of the Board of Directors. Shares issued
pursuant to the exercise of an unvested option are subject to the Company’s right of repurchase
which lapses over periods specified by the board of directors, generally four years from the date
of grant. In February 2006, the Company terminated all remaining unissued shares under the 1997
Plan. Although the 1997 Plan terminated, all outstanding options thereunder will continue to be
governed by their existing terms.

In October 2005, the Company’s Board of Directors adopted, and in December 2005 the stockholders
approved, the 2005 Equity Incentive Plan, as amended (the “2005 Plan”). A total of 3,400,000
shares of common stock have been reserved for issuance under the 2005 Plan.

Stock awards granted under the 2005 Plan may either be incentive stock options, nonstatutory stock
options, stock bonuses or rights to acquire restricted stock. Incentive stock options may be
granted to employees with exercise prices of no less than the fair value of the common stock on the
date of grant, as determined by the Board of Directors, and nonstatutory options may be granted to
employees, directors or consultants at exercise prices of no less than the fair value. If, at the
time the Company grants an option, the optionee directly or by attribution owns stock possessing
more than 10% of the total combined voting power of all classes of stock of the

1.

 

Company, the option price shall be at least 110% of the fair value and shall not be exercisable
more than five years after the date of grant. Options may be granted with vesting terms as
determined by the Board of Directors. Options expire no more than 10 years after the date of grant,
or earlier if employment is terminated.

Common stock options may include a provision whereby the holder, while an employee, director or
consultant, may elect at any time to exercise the option as to any part or all of the shares
subject to the option prior to the full vesting of the option. Any unvested shares so purchased are
subject to repurchase by the Company at its option and at a price equal to the original purchase
price of the stock. The Company does not consider the stock issued upon exercise of an unvested
stock option substantively exercised, and the cash paid for the exercise price is considered a
deposit or a prepayment of the exercise price that is recognized by the Company as a liability. As
the underlying shares vest, the deposit liability is reclassified as equity. As of November 30,
2010, no such shares are subject to the Company’s right of repurchase and excluded from
stockholders’ equity.

	 	 	 	 	 

	Options outstanding
	 	 	3,377,681	 
	Restricted awards outstanding
	 	 	38,675	 
	 
	 	 	 
	 
	 	 	3,416,356	 
	 
	 	 	 
	 
	 	 	 	 
	Option shares available for future grant
	 	 	863,389	 
	 
	 	 	 

Warrants to Purchase Common Stock As of November 30, 2010

As of November 30, 2010, warrants to purchase 4,646,393 shares of common stock were outstanding, of
which warrants to purchase 4,071,046 shares of common stock were exercisable at $1.45 per share and
warrants to purchase 575,347 shares of common stock were exercisable at $5.65 per share. The
warrants expire at various dates from June 2012 to September 2014. Additional information about
the warrants is available upon request.

     (iv) The Company has entered into the following agreements under which the Company is
obligated to register the sale of their securities under the 1933 Act:

Registration Rights Agreement, dated June 7, 2007, by and among Cardica, Inc., and the purchasers
listed on the signature pages thereto.

Registration Rights Agreement, dated September 25, 2009, by and among Cardica, Inc., and the
purchasers listed on the signature pages thereto.

Registration Rights Agreement, dated August 16, 2010, by and between Cardica, Inc., and Intuitive
Surgical Operations, Inc.

Schedule 3(e) — No Conflicts

On June 21, 2010, we received a letter, dated June 21, 2010, from the Listing Qualifications
Department of The NASDAQ Stock Market notifying us that we did not comply with the $50.0 million
minimum market capitalization for continued listing on The NASDAQ Global Market set

2.

 

forth in NASDAQ Marketplace Rule 5450(b)(2)(A) or the Minimum Market Capitalization Standard. On
September 16, 2010, we received a letter from the Listing Qualifications Department of The NASDAQ
Stock Market notifying us that we had regained compliance with the Minimum Market Capitalization
Standard.

Schedule 3(f) — 1934 Act Filings

     Not applicable.

Schedule 3(g) — Absence of Certain Changes

     Not applicable.

Schedule 3(h) — Litigation

On July 22, 2010, the Company was served with a complaint filed by Precision Made Products, LLC
(“PMP”) in state court in Ohio alleging claims for breach of contract by the Company for failing to
pay for certain services and/or products provided by PMP and claims for intentionally and/or
negligently making representations relating to the contract. The Company denies the allegations
in the Complaint. The Company has filed a counterclaim asserting claims for breach of contract for
PMP’s failure to perform and for damage to the Company arising from this breach.

Schedule 3(j) — Intellectual Property Rights

     Not applicable.

Schedule 3(l) — Title

     Not applicable.

Schedule 3(p) — Transactions with Affiliates

Sales of Stock and Warrants to Officers and Directors

In June 2007 and in September 2009, the Company entered into securities purchase agreements in
connection with private placements to accredited investors, some of which included certain
individuals and entities affiliated with the Company and officers of the Company. Pursuant to the
terms of the June 2007 and September 2009 securities purchase agreements, certain individuals and
entities affiliated with the Company and officers of the Company purchased shares of common stock
and warrants to purchase shares of common stock of the Company. In connection with the private
placements, the company also entered in registration rights agreements in June 2007 and September
2009 with the purchasers of common stock and warrants, which include certain individuals and
entities affiliated with the Company or its directors and officers of the Company.

3.

 

Life Insurance

The Company pays the premiums on a life insurance policy on Dr. Bernard A. Hausen’s behalf.

 [Remainder of Page Intentionally Left Blank]

4.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]